TechNavio's analysts forecast the Global Endometriosis market to grow at a
CAGR of 5.86 percent over the period 2012-2016. One of the key factors
contributing to this market growth is the increased number of incidence rates of
endometriosis. The market has also been witnessing an increased number of
awareness programs. However, poor safety and efficacy of existing drugs could
pose a challenge to the growth of this market.
The Global Endometriosis Market 2012-2016, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers
the Global Endometriosis market in the Americas, EMEA, and the APAC regions, its
market landscape, and growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space include AbbVie Inc., AstraZeneca
Plc., Bayer Inc., and Pfizer Inc.
The other vendors mentioned in the report are AEterna Zentaris Inc., KV
Pharmaceuticals Company, Neurocrine Biosciences Inc., and Repros Therapeutics
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
1. Executive Summary
2. List of Abbreviations
4. Market Research Methodology
4.1. Market Research Process
4.2. Research Design
4.3. Research Methodology
5. Scope of the Report
5.1. Market Overview
5.2. Product Offerings
5.3. Product Profiles
6. Market Landscape
6.1. Global Endometriosis Market 2012-2016
6.1.1. Market Size and Forecast
7. Five Force Analysis
8. Geographical Segmentation
9. Rate of Incidence and Prevalence
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1. AbbVie Inc.
17.1.1. Business Overview
17.1.2. Key Information
17.1.3. SWOT Analysis
17.2. Pfizer Inc.
17.2.1. Business Overview
17.2.2. Key Information
17.2.3. SWOT Analysis
17.3. AstraZeneca PLC.
17.3.1. Business Overview
17.3.2. Key Information
17.3.3. SWOT Analysis
17.4. Bayer Inc.
17.4.1. Business Overview
17.4.2. Key Information
17.4.3. SWOT Analysis
18. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Endometriosis Market 2012-2016 (US$ billion)
Exhibit 3: Therapies Used in the Treatment of Endometriosis
Exhibit 4: Therapies Used in the Treatment of Endometriosis (in percentage)
Exhibit 5: Global Endometriosis Market by Geographical Segmentation 2012